AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

AZTA · NASDAQ · Medical - Instruments & Supplies

Azenta (AZTA)

Provides sample-management products and multiomics services for life-sciences research.

$33.61

After hours−0.61 (−1.78%)

At close$34.22(+1.39%)

In millions of USD, except per-share figures

In millions	Q4 FY23Sep 2023	Q1 FY24Dec 2023	Q2 FY24Mar 2024	Q3 FY24Jun 2024	Q4 FY24Sep 2024	Q1 FY25Dec 2024	Q2 FY25Mar 2025	Q3 FY25Jun 2025	Q4 FY25Sep 2025	Q1 FY26Dec 2025	Q2 FY26Mar 2026	Q3 FY26Jun 2026
Revenue	172	142	136	144	151	147	143	144	159	149	145	161
Cost of revenue	112	85	76	79	82	79	78	76	87	85	83	89
Gross profit	61	56	61	65	68	69	66	68	72	64	62	72
	75	72	73	70	62	72	73	66	69	69	77	77
Research & development	9	7	8	7	8	7	7	7	8	9	9	9
Selling, general & administrative	66	64	65	63	55	65	66	59	61	59	68	67
Other expenses	0	0	0	0	0	0	0	0	0	0	0	1
Operating income	−15	−15	−12	−4	6	−4	−7	2	3	−5	−15	−4
	9	10	−3	5	−6	0	−3	2	3	3	−142	5
Interest income	11	10	10	8	6	4	4	5	5	5	4	4
Other non-operating income	−9	−10	3	−5	6	0	3	−2	−3	−3	142	−5
Income before tax	−6	−6	−15	0	0	−3	−11	3	6	−2	−157	1
Income tax expense	−8	1	1	1	2	4	8	3	−45	3	0	2
Net income from continuing operations	3	−7	−16	0	−2	−7	−18	1	52	−5	−157	−2
Discontinued operations	1	−9	−121	−6	−5	−4	−22	−53	−1	−10	−4	4
Net income	3	−16	−137	−7	−7	−11	−40	−53	51	−15	−161	2
EPS, basic	$0.06	−$0.28	−$2.47	−$0.12	−$0.10	−$0.29	−$0.88	−$1.15	$1.03	−$0.34	−$3.49	$0.05
EPS, diluted	$0.06	−$0.28	−$2.47	−$0.12	−$0.10	−$0.29	−$0.88	−$1.15	$1.02	−$0.34	−$3.49	$0.05
Weighted average shares, basic	60	57	55	53	49	46	46	46	46	46	46	45
Weighted average shares, diluted	60	57	55	53	49	46	46	46	46	46	46	45
EBITDA	17	9	0	15	24	11	3	18	21	12	−143	14
Depreciation & amortization	22	15	15	15	24	14	14	15	14	14	14	14
EBIT	−6	−6	−15	0	0	−3	−11	3	6	−2	−157	1